Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study
Titel:
Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study
Auteur:
Gue, Ying X. Memtsas, Vassilios Kanji, Rahim Wellsted, David M. Busby, Amanda Smith, Megan Vilar, Enric Ryding, Alisdair Arachchillage, Deepa J. Gorog, Diana A.